Cash Flow Statement
Growth Metrics

Opko Health (OPK) Gains from Investment Securities (2016 - 2025)

Opko Health's Gains from Investment Securities history spans 16 years, with the latest figure at -$20.6 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 145.2% year-over-year to -$20.6 million; the TTM value through Dec 2025 reached $63000.0, down 99.86%, while the annual FY2025 figure was $706215.0, 98.45% down from the prior year.
  • Gains from Investment Securities reached -$20.6 million in Q4 2025 per OPK's latest filing, down from $763000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $45.5 million in Q4 2024 to a low of -$20.6 million in Q4 2025.
  • Average Gains from Investment Securities over 5 years is $1.9 million, with a median of $189363.0 recorded in 2022.
  • Peak YoY movement for Gains from Investment Securities: tumbled 752.16% in 2022, then soared 4346.5% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $2.4 million in 2021, then plummeted by 752.16% to -$15.4 million in 2022, then soared by 106.66% to $1.0 million in 2023, then skyrocketed by 4346.5% to $45.5 million in 2024, then plummeted by 145.2% to -$20.6 million in 2025.
  • Per Business Quant, the three most recent readings for OPK's Gains from Investment Securities are -$20.6 million (Q4 2025), $763000.0 (Q3 2025), and $17.8 million (Q2 2025).